dc.contributor.author
Brito, Verónica
dc.contributor.author
Ginés Padrós, Silvia
dc.date.issued
2018-01-12T16:12:18Z
dc.date.issued
2018-01-12T16:12:18Z
dc.date.issued
2016-01-05
dc.date.issued
2018-01-12T16:12:18Z
dc.identifier
https://hdl.handle.net/2445/119016
dc.description.abstract
Huntington’s disease (HD) is a fatal
neurodegenerative disorder with a characteristic
phenotype including chorea and dystonia, uncoordinated
fine movements, cognitive decline and psychiatric
disturbances. Even though the clinical diagnosis of HD
relies on the manifestation of motor abnormalities, the
associated memory impairments have been growing in
prominence. Indeed, cognitive deficits are evident along
all the disease process even in the prodrome before any
motor diagnosis is given.
dc.format
application/pdf
dc.publisher
Impact Journals
dc.relation
Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.6646
dc.relation
Oncotarget, 2016, vol. 7, num. 1
dc.relation
https://doi.org/10.18632/oncotarget.6646
dc.rights
cc-by (c) Brito, Verónica; Ginés Padrós, Silvia, 2016
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Biomedicina)
dc.subject
Corea de Huntington
dc.subject
Malalties neurodegeneratives
dc.subject
Ganglis basals
dc.subject
Hipocamp (Cervell)
dc.subject
Huntington's chorea
dc.subject
Neurodegenerative Diseases
dc.subject
Hippocampus (Brain)
dc.title
p75NTR in Huntington's disease: beyond the basal ganglia
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
